NALOXONE HYDROCHLORIDE

NALOXONE HYDROCHLORIDE was reported 24312 times

NALOXONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RHESUS INCOMPATIBILITY 21 0.1736
1 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 75 0.1246
2 PROTEIN DEFICIENCY 7 0.0224
3 FUNGAL FOOT INFECTION 8 0.0182
4 RADICULAR PAIN 6 0.0172
5 NON-CARDIOGENIC PULMONARY OEDEMA 17 0.0161
6 TOOTH EROSION 19 0.0155
7 NAIL RIDGING 8 0.0152
8 BENIGN NEOPLASM OF THYROID GLAND 11 0.0150
9 LACK OF SPONTANEOUS SPEECH 6 0.0137
10 TONGUE MOVEMENT DISTURBANCE 10 0.0117
11 NEURODEGENERATIVE DISORDER 7 0.0113
12 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 11 0.0104
13 ANAEMIA OF CHRONIC DISEASE 9 0.0100
14 ACNE PUSTULAR 8 0.0098
15 BREECH PRESENTATION 12 0.0095
16 SUBSTANCE DEPENDENCE 6 0.0089
17 ENTEROCOCCAL SEPSIS 7 0.0086
18 VERTEBRAL FORAMINAL STENOSIS 6 0.0073
19 APNOEIC ATTACK 4 0.0071
20 MYOFASCIAL PAIN SYNDROME 5 0.0070
21 CERVICAL RADICULOPATHY 5 0.0070
22 GENERALISED ANXIETY DISORDER 10 0.0068
23 ESSENTIAL HYPERTENSION 12 0.0066
24 BLOOD UREA DECREASED 8 0.0064
25 NIPPLE DISORDER 4 0.0064
26 ACUTE LEFT VENTRICULAR FAILURE 4 0.0060
27 CANCER PAIN 15 0.0059
28 DRUG DETOXIFICATION 5 0.0056
29 GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0056
30 AORTIC VALVE SCLEROSIS 4 0.0055
31 JAUNDICE NEONATAL 10 0.0053
32 DISCOLOURED VOMIT 5 0.0052
33 FOETAL DISTRESS SYNDROME 11 0.0052
34 LUMBAR RADICULOPATHY 6 0.0052
35 STERNAL FRACTURE 6 0.0049
36 BONE DEMINERALISATION 5 0.0047
37 BLOOD CULTURE POSITIVE 14 0.0047
38 ENDOCRINE OPHTHALMOPATHY 4 0.0046
39 PILOERECTION 5 0.0046
40 ACUTE CHEST SYNDROME 4 0.0046
41 PERIRECTAL ABSCESS 5 0.0045
42 HYPERPARATHYROIDISM SECONDARY 11 0.0044
43 NEPHROGENIC ANAEMIA 20 0.0043
44 DELAYED RECOVERY FROM ANAESTHESIA 4 0.0042
45 DRUG DIVERSION 26 0.0042
46 ACTINOMYCOSIS 4 0.0042
47 THYROID MASS 16 0.0042
48 PAINFUL RESPIRATION 10 0.0041
49 OBSTRUCTIVE SLEEP APNOEA SYNDROME 6 0.0041
50 ANION GAP INCREASED 5 0.0037
51 NECROTISING FASCIITIS 13 0.0037
52 BLOOD CHLORIDE DECREASED 9 0.0035
53 CARBON DIOXIDE DECREASED 4 0.0035
54 HYPOCHLORAEMIA 4 0.0034
55 YAWNING 9 0.0034
56 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 4 0.0033
57 METABOLIC ENCEPHALOPATHY 10 0.0033
58 CHRONIC RESPIRATORY FAILURE 4 0.0033
59 PRODUCT ADMINISTRATION INTERRUPTED 26 0.0033
60 HYPERVOLAEMIA 16 0.0032
61 STREPTOCOCCAL INFECTION 17 0.0031
62 DEAFNESS NEUROSENSORY 10 0.0030
63 LUNG OPACITY 8 0.0030
64 ANXIETY DISORDER 10 0.0030
65 DENTAL CARIES 33 0.0030
66 SCREAMING 19 0.0030
67 PREMATURE DELIVERY 47 0.0029
68 CORNEAL ABRASION 4 0.0029
69 CERVICAL SPINAL STENOSIS 5 0.0029
70 PANCREATIC FAILURE 5 0.0028
71 ACUTE RESPIRATORY FAILURE 54 0.0028
72 HYPERTONIC BLADDER 8 0.0028
73 EXPOSURE VIA BREAST MILK 11 0.0028
74 LUMBAR SPINAL STENOSIS 8 0.0027
75 HOSPICE CARE 27 0.0027
76 HYPERACUSIS 10 0.0027
77 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 7 0.0027
78 REBOUND ACID HYPERSECRETION 8 0.0026
79 MIOSIS 21 0.0026
80 UNRESPONSIVE TO STIMULI 67 0.0026
81 HYPOPNOEA 9 0.0026
82 NASAL SEPTUM DEVIATION 5 0.0026
83 ENTHESOPATHY 4 0.0026
84 MAJOR DEPRESSION 18 0.0025
85 OSTEOLYSIS 5 0.0024
86 MALNUTRITION 27 0.0024
87 TRANSFUSION 25 0.0024
88 CLAVICLE FRACTURE 9 0.0023
89 AORTIC ARTERIOSCLEROSIS 6 0.0023
90 TOOTH INJURY 10 0.0023
91 MASTICATION DISORDER 7 0.0023
92 INFUSION SITE DISCHARGE 4 0.0023
93 ATELECTASIS 22 0.0023
94 SPINAL OSTEOARTHRITIS 20 0.0023
95 DRUG SCREEN NEGATIVE 4 0.0023
96 BRAIN DEATH 7 0.0023
97 DRUG WITHDRAWAL CONVULSIONS 4 0.0022
98 RESPIRATORY RATE DECREASED 7 0.0022
99 PATHOLOGICAL FRACTURE 11 0.0022
100 ARTHROPOD BITE 16 0.0022
101 POST-TRAUMATIC STRESS DISORDER 14 0.0021
102 INTERVERTEBRAL DISC DEGENERATION 19 0.0021
103 HAEMATOLOGICAL INFECTION 5 0.0020
104 SICKLE CELL ANAEMIA WITH CRISIS 32 0.0020
105 HYPERCAPNIA 6 0.0020
106 VASCULAR DEVICE INFECTION 9 0.0020
107 OSTEITIS 5 0.0020
108 EMERGENCY CARE 6 0.0020
109 SUBSTANCE ABUSE 16 0.0020
110 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
111 DIASTOLIC DYSFUNCTION 6 0.0019
112 CHRONIC GRAFT VERSUS HOST DISEASE 7 0.0019
113 DEVICE CONNECTION ISSUE 4 0.0019
114 CATHETER SITE ERYTHEMA 4 0.0019
115 COMPRESSION FRACTURE 10 0.0019
116 LOOSE TOOTH 6 0.0019
117 HYPERPHOSPHATAEMIA 4 0.0019
118 EXOPHTHALMOS 4 0.0019
119 BRADYPNOEA 5 0.0019
120 HEPATIC LESION 8 0.0018
121 EXPOSED BONE IN JAW 4 0.0018
122 DECUBITUS ULCER 15 0.0018
123 IMPAIRED GASTRIC EMPTYING 25 0.0018
124 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 14 0.0018
125 ANAL INCONTINENCE 16 0.0018
126 IDIOPATHIC PULMONARY FIBROSIS 7 0.0018
127 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
128 ABDOMINAL HERNIA 8 0.0018
129 FAILURE TO THRIVE 9 0.0017
130 DRUG WITHDRAWAL SYNDROME 152 0.0017
131 FLAT AFFECT 4 0.0017
132 DYSPNOEA AT REST 5 0.0017
133 THROMBOPHLEBITIS 6 0.0017
134 END STAGE RENAL DISEASE 31 0.0017
135 APPETITE DISORDER 11 0.0017
136 DIABETIC FOOT 5 0.0016
137 TOOTH FRACTURE 18 0.0016
138 RESPIRATORY DEPRESSION 20 0.0016
139 BONE CANCER 7 0.0016
140 PRE-EXISTING CONDITION IMPROVED 10 0.0016
141 CHRONIC SINUSITIS 6 0.0016
142 MENTAL STATUS CHANGES 44 0.0016
143 METASTASES TO PERITONEUM 4 0.0016
144 TROPONIN INCREASED 12 0.0016
145 TOOTH ABSCESS 16 0.0016
146 BURSITIS 19 0.0016
147 VENTRICULAR HYPOKINESIA 5 0.0016
148 VITAMIN D DEFICIENCY 15 0.0015
149 RESPIRATORY ACIDOSIS 6 0.0015
150 ORAL CANDIDIASIS 20 0.0015
151 SERUM FERRITIN INCREASED 8 0.0015
152 PSEUDOMONAS INFECTION 13 0.0015
153 BLOOD ALBUMIN DECREASED 12 0.0015
154 BLOOD CALCIUM DECREASED 17 0.0015
155 ODYNOPHAGIA 9 0.0015
156 LEARNING DISABILITY 8 0.0015
157 ANIMAL BITE 4 0.0015
158 BLOOD POTASSIUM ABNORMAL 4 0.0015
159 CHRONIC KIDNEY DISEASE 114 0.0015
160 ALCOHOL ABUSE 4 0.0015
161 GASTRIC PERFORATION 4 0.0015
162 PUSTULAR PSORIASIS 5 0.0015
163 LEFT VENTRICULAR FAILURE 5 0.0015
164 OSTEOPENIA 22 0.0014
165 ANHEDONIA 38 0.0014
166 RIGHT VENTRICULAR FAILURE 10 0.0014
167 NEUTROPHIL COUNT ABNORMAL 4 0.0014
168 HAEMATOCRIT DECREASED 28 0.0014
169 HAND FRACTURE 10 0.0014
170 BONE LESION 5 0.0014
171 DRUG TOLERANCE 7 0.0014
172 INSURANCE ISSUE 21 0.0014
173 TOXICITY TO VARIOUS AGENTS 230 0.0014
174 IMMUNOSUPPRESSION 12 0.0014
175 RHINITIS ALLERGIC 6 0.0013
176 PROTEIN TOTAL DECREASED 5 0.0013
177 LEUKOCYTOSIS 24 0.0013
178 HAEMOGLOBIN INCREASED 6 0.0013
179 ISCHAEMIC CARDIOMYOPATHY 4 0.0013
180 IRON DEFICIENCY ANAEMIA 12 0.0013
181 SPINAL OPERATION 16 0.0013
182 OESOPHAGEAL DISORDER 5 0.0013
183 GINGIVITIS 7 0.0013
184 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
185 TIBIA FRACTURE 6 0.0013
186 HYPOXIA 45 0.0013
187 BLOOD CREATININE DECREASED 4 0.0013
188 SINUS TACHYCARDIA 18 0.0013
189 OESOPHAGEAL PAIN 5 0.0013
190 WITHDRAWAL SYNDROME 53 0.0013
191 ORTHOPNOEA 4 0.0013
192 OCULAR DISCOMFORT 14 0.0012
193 HUMERUS FRACTURE 6 0.0012
194 SPINAL FUSION SURGERY 5 0.0012
195 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
196 PERIPHERAL VENOUS DISEASE 5 0.0012
197 FEELING COLD 34 0.0012
198 SOMNAMBULISM 8 0.0012
199 INFUSION SITE HAEMORRHAGE 4 0.0012
200 BLOOD URIC ACID INCREASED 7 0.0012
201 GENERALISED OEDEMA 15 0.0012
202 GASTROINTESTINAL SOUNDS ABNORMAL 6 0.0012
203 STRESS CARDIOMYOPATHY 7 0.0012
204 CAESAREAN SECTION 14 0.0012
205 CONGESTIVE CARDIOMYOPATHY 5 0.0012
206 BRAIN INJURY 12 0.0012
207 JOINT RANGE OF MOTION DECREASED 16 0.0012
208 METASTASES TO SPINE 4 0.0012
209 ASPIRATION 13 0.0012
210 FLANK PAIN 11 0.0012
211 INTERVERTEBRAL DISC DISORDER 5 0.0012
212 ALCOHOLISM 5 0.0012
213 PERIPHERAL VASCULAR DISORDER 6 0.0012
214 PREMATURE BABY 35 0.0012
215 JOINT EFFUSION 8 0.0012
216 BLOOD MAGNESIUM DECREASED 10 0.0012
217 BLOOD CREATININE ABNORMAL 4 0.0012
218 APNOEA 9 0.0012
219 SLEEP APNOEA SYNDROME 22 0.0012
220 CAROTID ARTERY STENOSIS 4 0.0011
221 ONYCHOMYCOSIS 5 0.0011
222 BLOOD LACTIC ACID INCREASED 6 0.0011
223 INCONTINENCE 12 0.0011
224 ABDOMINAL ABSCESS 5 0.0011
225 PHYSICAL DISABILITY 5 0.0011
226 ELECTROLYTE IMBALANCE 13 0.0011
227 DISABILITY 22 0.0011
228 IRON DEFICIENCY 5 0.0011
229 MYDRIASIS 14 0.0011
230 LUMBAR VERTEBRAL FRACTURE 5 0.0011
231 HYPERKERATOSIS 6 0.0011
232 BLINDNESS TRANSIENT 8 0.0011
233 COORDINATION ABNORMAL 15 0.0011
234 PULMONARY OEDEMA 48 0.0011
235 RIB FRACTURE 22 0.0011
236 NEURALGIA 26 0.0011
237 ACUTE PULMONARY OEDEMA 6 0.0011
238 DYSPNOEA EXERTIONAL 40 0.0011
239 CORONAVIRUS INFECTION 7 0.0011
240 RESPIRATORY FAILURE 77 0.0011
241 PULSE ABSENT 5 0.0011
242 ACIDOSIS 8 0.0010
243 SUBCUTANEOUS ABSCESS 5 0.0010
244 PNEUMONIA ASPIRATION 26 0.0010
245 METASTASES TO BONE 17 0.0010
246 DIZZINESS POSTURAL 10 0.0010
247 JOINT INJURY 22 0.0010
248 TACHYPNOEA 14 0.0010
249 HYPOALBUMINAEMIA 8 0.0010
250 LETHARGY 59 0.0010
251 MULTIPLE ALLERGIES 8 0.0010
252 RENAL TUBULAR NECROSIS 10 0.0010
253 ENCEPHALOPATHY 25 0.0010
254 PANCREATIC DISORDER 5 0.0010
255 URINARY INCONTINENCE 30 0.0010
256 DRUG SCREEN POSITIVE 8 0.0010
257 DIABETIC NEUROPATHY 5 0.0010
258 RENAL CYST 8 0.0010
259 ABDOMINAL TENDERNESS 5 0.0010
260 IMMUNODEFICIENCY 15 0.0010
261 HYPERLIPIDAEMIA 12 0.0010
262 VAGINAL DISCHARGE 10 0.0010
263 OVERDOSE 213 0.0010
264 SEPSIS 109 0.0010
265 UROSEPSIS 9 0.0010
266 CACHEXIA 5 0.0010
267 PRODUCT DISTRIBUTION ISSUE 9 0.0010
268 PULMONARY HYPERTENSION 20 0.0010
269 SPINAL DISORDER 9 0.0009
270 ANGER 32 0.0009
271 DRUG WITHDRAWAL SYNDROME NEONATAL 14 0.0009
272 BUNDLE BRANCH BLOCK LEFT 4 0.0009
273 RESPIRATORY DISTRESS 26 0.0009
274 OBESITY 15 0.0009
275 AORTIC VALVE INCOMPETENCE 4 0.0009
276 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
277 OSTEOMYELITIS 17 0.0009
278 SPINAL PAIN 11 0.0009
279 TASTE DISORDER 19 0.0009
280 DRUG DEPENDENCE 150 0.0009
281 NECK PAIN 52 0.0009
282 METASTATIC NEOPLASM 4 0.0009
283 OXYGEN SATURATION DECREASED 52 0.0009
284 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
285 ACUTE KIDNEY INJURY 140 0.0009
286 DIVERTICULUM INTESTINAL 4 0.0009
287 BOWEL MOVEMENT IRREGULARITY 7 0.0009
288 WOUND INFECTION 10 0.0009
289 RENAL FAILURE CHRONIC 7 0.0009
290 TUMOUR LYSIS SYNDROME 8 0.0009
291 HEAD DISCOMFORT 16 0.0009
292 CATHETERISATION CARDIAC 4 0.0009
293 TERMINAL STATE 6 0.0009
294 MUSCLE SPASTICITY 11 0.0009
295 SMALL INTESTINAL OBSTRUCTION 11 0.0009
296 GASTROINTESTINAL INFECTION 8 0.0009
297 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
298 GASTROENTERITIS VIRAL 16 0.0009
299 ILEUS 11 0.0009
300 SEROTONIN SYNDROME 17 0.0009
301 PERIORBITAL SWELLING 5 0.0009
302 PELVIC PAIN 16 0.0009
303 PULMONARY MASS 13 0.0009
304 RESPIRATION ABNORMAL 6 0.0009
305 SENSORY LOSS 7 0.0009
306 HYPOKALAEMIA 40 0.0009
307 RALES 5 0.0009
308 WEIGHT FLUCTUATION 9 0.0009
309 HYPOVOLAEMIA 5 0.0009
310 SKIN ULCER 22 0.0009
311 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
312 RETCHING 18 0.0008
313 COGNITIVE DISORDER 39 0.0008
314 TOOTH INFECTION 11 0.0008
315 PANIC REACTION 6 0.0008
316 GANGRENE 5 0.0008
317 DRUG ABUSE 69 0.0008
318 CYANOSIS 13 0.0008
319 MUSCLE TWITCHING 19 0.0008
320 RENAL FAILURE 109 0.0008
321 CARDIOMEGALY 10 0.0008
322 PAIN IN JAW 23 0.0008
323 VENTRICULAR FIBRILLATION 9 0.0008
324 NERVE INJURY 9 0.0008
325 MUSCLE STRAIN 7 0.0008
326 MULTIPLE DRUG OVERDOSE 4 0.0008
327 HEPATIC STEATOSIS 15 0.0008
328 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
329 HYPERSOMNIA 23 0.0008
330 FEBRILE NEUTROPENIA 53 0.0008
331 CORONARY ARTERY STENOSIS 4 0.0008
332 EMPHYSEMA 8 0.0008
333 LUNG INFILTRATION 7 0.0008
334 FOOT FRACTURE 15 0.0008
335 CARPAL TUNNEL SYNDROME 11 0.0008
336 AMMONIA INCREASED 4 0.0008
337 HIP ARTHROPLASTY 12 0.0008
338 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
339 SEPTIC SHOCK 34 0.0008
340 ENTERITIS 5 0.0008
341 NEUTROPHIL COUNT INCREASED 8 0.0008
342 FEMORAL NECK FRACTURE 4 0.0008
343 PROCTALGIA 5 0.0008
344 INCOHERENT 5 0.0008
345 TOOTH LOSS 16 0.0008
346 URINARY TRACT INFECTION 131 0.0008
347 ILLNESS 79 0.0008
348 NERVE COMPRESSION 7 0.0008
349 ATRIAL FLUTTER 6 0.0008
350 DELIRIUM 26 0.0007
351 FOOD POISONING 4 0.0007
352 HEREDITARY ANGIOEDEMA 8 0.0007
353 CARDIOMYOPATHY 11 0.0007
354 ARTERIOSCLEROSIS 7 0.0007
355 SYRINGE ISSUE 13 0.0007
356 ANAL ABSCESS 4 0.0007
357 FIBROMYALGIA 18 0.0007
358 BLOOD POTASSIUM INCREASED 12 0.0007
359 POISONING DELIBERATE 7 0.0007
360 ACCIDENTAL OVERDOSE 27 0.0007
361 BIPOLAR DISORDER 8 0.0007
362 CYTOPENIA 9 0.0007
363 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
364 CELLULITIS 37 0.0007
365 PULMONARY THROMBOSIS 8 0.0007
366 FAECALOMA 4 0.0007
367 ECCHYMOSIS 5 0.0007
368 LOSS OF CONSCIOUSNESS 93 0.0007
369 SPINAL COMPRESSION FRACTURE 6 0.0007
370 RESPIRATORY ARREST 20 0.0007
371 LYMPHOEDEMA 5 0.0007
372 CYSTIC FIBROSIS 4 0.0007
373 BLOOD UREA INCREASED 12 0.0007
374 DEMENTIA 20 0.0007
375 RESTLESS LEGS SYNDROME 13 0.0007
376 DEVICE RELATED INFECTION 11 0.0007
377 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 37 0.0007
378 INABILITY TO AFFORD MEDICATION 7 0.0007
379 CIRCULATORY COLLAPSE 12 0.0007
380 EATING DISORDER 15 0.0007
381 BLOOD BILIRUBIN INCREASED 19 0.0007
382 MYOCARDIAL ISCHAEMIA 8 0.0007
383 METASTASES TO LUNG 8 0.0007
384 PRODUCTIVE COUGH 33 0.0007
385 THERAPY NON-RESPONDER 31 0.0007
386 MOTOR DYSFUNCTION 7 0.0007
387 SENSORY DISTURBANCE 11 0.0007
388 HYPERKALAEMIA 24 0.0007
389 EUPHORIC MOOD 7 0.0007
390 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
391 ORAL DISORDER 5 0.0007
392 COLD SWEAT 12 0.0007
393 ASCITES 20 0.0007
394 WOUND 19 0.0007
395 DYSURIA 25 0.0007
396 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
397 DECREASED INTEREST 4 0.0007
398 CARDIAC ARREST 56 0.0007
399 COVID-19 PNEUMONIA 8 0.0007
400 LOWER LIMB FRACTURE 13 0.0007
401 CHOLECYSTITIS 8 0.0007
402 MUSCLE RIGIDITY 8 0.0007
403 RED BLOOD CELL COUNT DECREASED 19 0.0007
404 DYSPHAGIA 63 0.0007
405 EMOTIONAL DISTRESS 80 0.0007
406 DEPRESSED LEVEL OF CONSCIOUSNESS 26 0.0007
407 EXOSTOSIS 6 0.0007
408 CONFUSIONAL STATE 106 0.0007
409 ANAEMIA 124 0.0006
410 SURGERY 38 0.0006
411 HYPOMAGNESAEMIA 9 0.0006
412 ANKLE FRACTURE 10 0.0006
413 SKIN LACERATION 7 0.0006
414 PLEURAL EFFUSION 39 0.0006
415 SOMNOLENCE 129 0.0006
416 RENAL INJURY 19 0.0006
417 DEVICE OCCLUSION 9 0.0006
418 MUSCULOSKELETAL DISCOMFORT 11 0.0006
419 HYPONATRAEMIA 36 0.0006
420 OSTEOARTHRITIS 27 0.0006
421 BLOOD SODIUM DECREASED 12 0.0006
422 SEASONAL ALLERGY 9 0.0006
423 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
424 HYPOCALCAEMIA 12 0.0006
425 CONSTIPATION 138 0.0006
426 SPUTUM DISCOLOURED 6 0.0006
427 OSTEOPOROSIS 26 0.0006
428 PROTEINURIA 12 0.0006
429 NEUROPATHY PERIPHERAL 60 0.0006
430 TRICUSPID VALVE INCOMPETENCE 5 0.0006
431 MATERNAL EXPOSURE DURING PREGNANCY 56 0.0006
432 HYPOTENSION 126 0.0006
433 LIMB INJURY 17 0.0006
434 ORAL PAIN 14 0.0006
435 HAEMOGLOBIN ABNORMAL 4 0.0006
436 MENTAL DISORDER 27 0.0006
437 RHINITIS 5 0.0006
438 TACHYCARDIA 55 0.0006
439 VOMITING 291 0.0006
440 FALL 206 0.0006
441 MITRAL VALVE INCOMPETENCE 7 0.0006
442 HIATUS HERNIA 8 0.0006
443 IMPAIRED DRIVING ABILITY 7 0.0006
444 BACK PAIN 143 0.0006
445 BACK DISORDER 10 0.0006
446 POST PROCEDURAL INFECTION 5 0.0006
447 DERMATITIS CONTACT 7 0.0006
448 HEPATOMEGALY 6 0.0006
449 NEOPLASM 7 0.0006
450 COMA 29 0.0006
451 MULTIPLE FRACTURES 10 0.0006
452 IMPAIRED WORK ABILITY 13 0.0006
453 MIGRAINE 58 0.0006
454 PULMONARY CONGESTION 8 0.0006
455 LIGAMENT SPRAIN 6 0.0006
456 OSTEONECROSIS OF JAW 15 0.0006
457 SARS-COV-2 TEST POSITIVE 8 0.0006
458 DISORIENTATION 24 0.0006
459 PERICARDIAL EFFUSION 14 0.0006
460 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
461 UPPER LIMB FRACTURE 12 0.0006
462 ANXIETY 171 0.0006
463 OVARIAN CYST 6 0.0006
464 BLOOD POTASSIUM DECREASED 18 0.0006
465 HEART RATE DECREASED 21 0.0006
466 PRODUCT PRESCRIBING ISSUE 13 0.0006
467 GASTROOESOPHAGEAL REFLUX DISEASE 48 0.0006
468 APHASIA 18 0.0006
469 BREAST MASS 4 0.0006
470 ECONOMIC PROBLEM 9 0.0006
471 SPEECH DISORDER 31 0.0006
472 ACCIDENT 7 0.0006
473 HEPATIC CIRRHOSIS 11 0.0006
474 WRIST FRACTURE 7 0.0006
475 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
476 MUSCULOSKELETAL CHEST PAIN 9 0.0006
477 EJECTION FRACTION DECREASED 9 0.0006
478 LARGE INTESTINE POLYP 4 0.0006
479 PYELONEPHRITIS 5 0.0006
480 LARGE INTESTINE PERFORATION 4 0.0006
481 THERAPY INTERRUPTED 41 0.0006
482 POST PROCEDURAL COMPLICATION 11 0.0006
483 GROIN PAIN 5 0.0006
484 GAIT INABILITY 19 0.0006
485 MEMORY IMPAIRMENT 78 0.0006
486 JOINT DISLOCATION 6 0.0006
487 EYE PAIN 32 0.0006
488 HYPERCALCAEMIA 7 0.0006
489 LYMPHOCYTE COUNT DECREASED 10 0.0006
490 BRADYCARDIA 30 0.0006
491 PNEUMONIA 183 0.0006
492 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
493 PAIN 347 0.0006
494 ATRIAL FIBRILLATION 55 0.0006
495 SCIATICA 9 0.0006
496 DIVERTICULUM 4 0.0006
497 SEIZURE 65 0.0006
498 STOMATITIS 34 0.0006
499 LIVER FUNCTION TEST INCREASED 12 0.0006
500 PARALYSIS 8 0.0006
501 AGITATION 41 0.0006
502 RENAL DISORDER 26 0.0006
503 GOUT 10 0.0006
504 HAEMOGLOBIN DECREASED 57 0.0006
505 DEHYDRATION 74 0.0006
506 BRAIN OEDEMA 7 0.0006
507 COLITIS 21 0.0006
508 OROPHARYNGEAL DISCOMFORT 5 0.0006
509 BLOOD PRESSURE ABNORMAL 11 0.0006
510 FLUID OVERLOAD 8 0.0005
511 LIMB DISCOMFORT 17 0.0005
512 SPINAL FRACTURE 11 0.0005
513 BONE DISORDER 10 0.0005
514 OSTEONECROSIS 18 0.0005
515 ROTATOR CUFF SYNDROME 7 0.0005
516 FEEDING DISORDER 11 0.0005
517 GRAND MAL CONVULSION 5 0.0005
518 DYSKINESIA 22 0.0005
519 CEREBRAL DISORDER 4 0.0005
520 URINARY RETENTION 18 0.0005
521 PLASMA CELL MYELOMA 21 0.0005
522 HAEMOPTYSIS 15 0.0005
523 HEPATIC ENCEPHALOPATHY 5 0.0005
524 SNEEZING 12 0.0005
525 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
526 PHOTOPHOBIA 10 0.0005
527 SQUAMOUS CELL CARCINOMA 5 0.0005
528 THROMBOCYTOPENIA 59 0.0005
529 BRONCHITIS 39 0.0005
530 BLOOD URINE PRESENT 10 0.0005
531 BLOOD PRESSURE DECREASED 35 0.0005
532 INTENTIONAL DOSE OMISSION 15 0.0005
533 SWELLING 49 0.0005
534 AMNESIA 34 0.0005
535 KNEE ARTHROPLASTY 11 0.0005
536 FEELING HOT 32 0.0005
537 QUALITY OF LIFE DECREASED 7 0.0005
538 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25 0.0005
539 AGGRESSION 26 0.0005
540 FOOD ALLERGY 4 0.0005
541 ORTHOSTATIC HYPOTENSION 9 0.0005
542 ABDOMINAL PAIN 120 0.0005
543 STAPHYLOCOCCAL INFECTION 17 0.0005
544 INTENTIONAL PRODUCT USE ISSUE 45 0.0005
545 IRRITABLE BOWEL SYNDROME 11 0.0005
546 HAEMATEMESIS 13 0.0005
547 HYPERHIDROSIS 66 0.0005
548 INJURY 36 0.0005
549 METASTASES TO LIVER 9 0.0005
550 SKIN LESION 14 0.0005
551 PERIPHERAL COLDNESS 7 0.0005
552 THROMBOSIS 41 0.0005
553 AFFECTIVE DISORDER 4 0.0005
554 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
555 DECREASED APPETITE 118 0.0005
556 DEEP VEIN THROMBOSIS 33 0.0005
557 PRODUCT USE COMPLAINT 8 0.0005
558 MALIGNANT NEOPLASM PROGRESSION 52 0.0005
559 HOSPITALISATION 78 0.0005
560 BACTERAEMIA 6 0.0005
561 SINUS DISORDER 10 0.0005
562 FURUNCLE 4 0.0005
563 GALLBLADDER DISORDER 9 0.0005
564 ROAD TRAFFIC ACCIDENT 21 0.0005
565 NEPHROLITHIASIS 23 0.0005
566 POLYNEUROPATHY 6 0.0005
567 BLISTER 28 0.0005
568 CYTOKINE RELEASE SYNDROME 10 0.0005
569 HAEMATURIA 17 0.0005
570 BONE PAIN 29 0.0005
571 HYPERGLYCAEMIA 18 0.0005
572 MUSCLE DISORDER 4 0.0005
573 HYPOTHERMIA 5 0.0005
574 NAUSEA 389 0.0005
575 HALLUCINATION 37 0.0005
576 WEIGHT DECREASED 136 0.0005
577 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
578 IMPAIRED QUALITY OF LIFE 7 0.0005
579 CHILLS 57 0.0005
580 TEMPERATURE INTOLERANCE 5 0.0005
581 VENTRICULAR TACHYCARDIA 8 0.0005
582 HAIR COLOUR CHANGES 6 0.0005
583 TOOTH EXTRACTION 6 0.0005
584 GASTROENTERITIS 7 0.0005
585 ABNORMAL BEHAVIOUR 19 0.0005
586 PETECHIAE 5 0.0005
587 DEPRESSION 109 0.0005
588 BONE DENSITY DECREASED 15 0.0005
589 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
590 FRACTURE 9 0.0005
591 PSYCHOTIC DISORDER 14 0.0005
592 CANDIDA INFECTION 8 0.0005
593 GASTRIC ULCER 9 0.0005
594 COVID-19 83 0.0005
595 CARDIAC FAILURE CONGESTIVE 38 0.0005
596 FLUID RETENTION 24 0.0005
597 DIVERTICULITIS 13 0.0005
598 FATIGUE 365 0.0005
599 CONTUSION 45 0.0005
600 PANIC ATTACK 17 0.0005
601 PRODUCT DOSE OMISSION ISSUE 137 0.0005
602 IRRITABILITY 28 0.0005
603 INFUSION SITE PAIN 6 0.0005
604 NIGHT SWEATS 15 0.0005
605 POOR QUALITY SLEEP 10 0.0005
606 CHEST PAIN 86 0.0005
607 HAEMATOMA 12 0.0005
608 UNEVALUABLE EVENT 35 0.0005
609 CARDIAC MURMUR 4 0.0005
610 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
611 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
612 MUSCLE SPASMS 84 0.0005
613 OESOPHAGITIS 5 0.0005
614 CHOLELITHIASIS 15 0.0005
615 BEDRIDDEN 6 0.0005
616 BLOOD CALCIUM INCREASED 4 0.0005
617 GASTRITIS 12 0.0005
618 HYPOGLYCAEMIA 22 0.0005
619 PRESYNCOPE 11 0.0005
620 FOOT DEFORMITY 5 0.0005
621 TOOTH DISORDER 10 0.0004
622 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
623 THERAPY PARTIAL RESPONDER 7 0.0004
624 FACIAL PAIN 4 0.0004
625 BRAIN FOG 7 0.0004
626 INTESTINAL PERFORATION 5 0.0004
627 DYSSTASIA 13 0.0004
628 DISTURBANCE IN ATTENTION 24 0.0004
629 BLOOD CREATININE INCREASED 29 0.0004
630 ASTHENIA 167 0.0004
631 SINUS CONGESTION 6 0.0004
632 DEVELOPMENTAL DELAY 4 0.0004
633 HEAD INJURY 14 0.0004
634 TOOTHACHE 8 0.0004
635 PNEUMOTHORAX 7 0.0004
636 DRUG TOXICITY 6 0.0004
637 NERVOUSNESS 23 0.0004
638 GAIT DISTURBANCE 84 0.0004
639 ABSCESS 7 0.0004
640 DYSPNOEA 248 0.0004
641 GENERAL PHYSICAL HEALTH DETERIORATION 50 0.0004
642 HYPOPHAGIA 11 0.0004
643 SYNCOPE 43 0.0004
644 HYPERTENSION 91 0.0004
645 POST PROCEDURAL HAEMORRHAGE 5 0.0004
646 NEPHROPATHY 4 0.0004
647 DIARRHOEA HAEMORRHAGIC 4 0.0004
648 EPISTAXIS 32 0.0004
649 SPLENOMEGALY 5 0.0004
650 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
651 MANIA 7 0.0004
652 RASH GENERALISED 11 0.0004
653 MUSCULAR WEAKNESS 48 0.0004
654 ABDOMINAL DISTENSION 44 0.0004
655 DIARRHOEA 272 0.0004
656 DEAFNESS 11 0.0004
657 MUCOSAL INFLAMMATION 11 0.0004
658 COAGULOPATHY 7 0.0004
659 SEDATION 11 0.0004
660 ARTHRITIS 33 0.0004
661 JOINT STIFFNESS 11 0.0004
662 OEDEMA PERIPHERAL 51 0.0004
663 CARDIOGENIC SHOCK 6 0.0004
664 CARDIAC DISORDER 39 0.0004
665 RENAL IMPAIRMENT 35 0.0004
666 FAECES DISCOLOURED 9 0.0004
667 INFECTION 60 0.0004
668 HEPATITIS C 5 0.0004
669 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
670 HEART RATE INCREASED 41 0.0004
671 BURNING SENSATION 29 0.0004
672 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
673 MENTAL IMPAIRMENT 10 0.0004
674 ADRENAL INSUFFICIENCY 5 0.0004
675 PANCYTOPENIA 23 0.0004
676 OROPHARYNGEAL PAIN 38 0.0004
677 HAEMORRHOIDS 8 0.0004
678 FEELING ABNORMAL 98 0.0004
679 PERIPHERAL SWELLING 63 0.0004
680 MELAENA 9 0.0004
681 KIDNEY INFECTION 8 0.0004
682 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
683 KNEE OPERATION 4 0.0004
684 PARANOIA 7 0.0004
685 SKIN HAEMORRHAGE 6 0.0004
686 PALLOR 11 0.0004
687 HIP FRACTURE 13 0.0004
688 PHARYNGITIS 5 0.0004
689 CYST 5 0.0004
690 PAIN IN EXTREMITY 118 0.0004
691 PULMONARY EMBOLISM 38 0.0004
692 SECRETION DISCHARGE 5 0.0004
693 POISONING 5 0.0004
694 PRODUCT ADMINISTRATION ERROR 8 0.0004
695 SUICIDE ATTEMPT 24 0.0004
696 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
697 DEVICE FAILURE 6 0.0004
698 VIRAL INFECTION 13 0.0004
699 PYREXIA 135 0.0004
700 EAR DISCOMFORT 4 0.0004
701 HYPERBILIRUBINAEMIA 4 0.0004
702 COUGH 108 0.0004
703 POLLAKIURIA 16 0.0004
704 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 69 0.0004
705 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
706 DRY MOUTH 31 0.0004
707 HAEMATOCHEZIA 21 0.0004
708 DEPRESSED MOOD 20 0.0004
709 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
710 ARTHRALGIA 157 0.0004
711 CYSTITIS 12 0.0004
712 DYSPHONIA 22 0.0004
713 HYPOTHYROIDISM 12 0.0004
714 METABOLIC ACIDOSIS 12 0.0004
715 BLOOD PRESSURE FLUCTUATION 9 0.0004
716 ABDOMINAL PAIN UPPER 77 0.0004
717 TREMOR 62 0.0004
718 MENSTRUATION IRREGULAR 10 0.0004
719 LABORATORY TEST ABNORMAL 11 0.0004
720 BREAST CANCER METASTATIC 4 0.0004
721 LOCALISED INFECTION 9 0.0004
722 DYSARTHRIA 14 0.0004
723 FEAR 10 0.0004
724 FEELING JITTERY 7 0.0004
725 PNEUMONITIS 10 0.0004
726 BLOOD PRESSURE INCREASED 56 0.0004
727 GINGIVAL BLEEDING 5 0.0004
728 ACUTE HEPATIC FAILURE 5 0.0004
729 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
730 DRUG LEVEL INCREASED 6 0.0004
731 HERNIA 7 0.0004
732 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
733 SINUSITIS 37 0.0004
734 HYPOAESTHESIA 54 0.0004
735 INSOMNIA 96 0.0004
736 EAR PAIN 7 0.0004
737 HYPERTENSIVE CRISIS 4 0.0004
738 HUNGER 5 0.0004
739 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
740 NASAL CONGESTION 21 0.0004
741 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
742 EYE INFECTION 4 0.0004
743 SWELLING FACE 23 0.0004
744 ABDOMINAL DISCOMFORT 59 0.0004
745 PRODUCT USE ISSUE 66 0.0004
746 ERECTILE DYSFUNCTION 9 0.0004
747 SCAR 6 0.0004
748 MICTURITION URGENCY 4 0.0003
749 INTERNAL HAEMORRHAGE 4 0.0003
750 SUICIDAL IDEATION 32 0.0003
751 DEATH 301 0.0003
752 HEADACHE 219 0.0003
753 TINNITUS 16 0.0003
754 FULL BLOOD COUNT DECREASED 7 0.0003
755 DEVICE DEFECTIVE 6 0.0003
756 RESPIRATORY TRACT INFECTION 9 0.0003
757 NEOPLASM PROGRESSION 12 0.0003
758 FOETAL EXPOSURE DURING PREGNANCY 28 0.0003
759 HYPOKINESIA 5 0.0003
760 MUSCULOSKELETAL PAIN 18 0.0003
761 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
762 BODY TEMPERATURE INCREASED 7 0.0003
763 MUSCULOSKELETAL STIFFNESS 30 0.0003
764 DIABETES MELLITUS 26 0.0003
765 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
766 NEUTROPENIA 46 0.0003
767 PLATELET COUNT DECREASED 36 0.0003
768 WHEEZING 20 0.0003
769 ATAXIA 4 0.0003
770 RHABDOMYOLYSIS 14 0.0003
771 DYSPEPSIA 33 0.0003
772 MYOCLONUS 4 0.0003
773 MOBILITY DECREASED 24 0.0003
774 EXPIRED PRODUCT ADMINISTERED 11 0.0003
775 DRY SKIN 44 0.0003
776 TYPE 2 DIABETES MELLITUS 11 0.0003
777 DIZZINESS 162 0.0003
778 TENDONITIS 5 0.0003
779 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
780 INTESTINAL OBSTRUCTION 12 0.0003
781 ARRHYTHMIA 15 0.0003
782 ABDOMINAL PAIN LOWER 8 0.0003
783 CONVULSION 18 0.0003
784 NEOPLASM MALIGNANT 21 0.0003
785 MOOD SWINGS 10 0.0003
786 PULMONARY FIBROSIS 6 0.0003
787 DISEASE PROGRESSION 37 0.0003
788 CARDIAC FAILURE 25 0.0003
789 TREATMENT NONCOMPLIANCE 17 0.0003
790 PRESCRIBED OVERDOSE 6 0.0003
791 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
792 MUSCLE TIGHTNESS 5 0.0003
793 MULTIPLE SCLEROSIS RELAPSE 21 0.0003
794 MALAISE 133 0.0003
795 EAR INFECTION 8 0.0003
796 RESTLESSNESS 11 0.0003
797 FUNGAL INFECTION 10 0.0003
798 MYALGIA 51 0.0003
799 LEUKOPENIA 15 0.0003
800 SLEEP DISORDER 21 0.0003
801 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
802 ILL-DEFINED DISORDER 18 0.0003
803 DEPENDENCE 16 0.0003
804 THROAT IRRITATION 13 0.0003
805 ANAPHYLACTIC REACTION 16 0.0003
806 BALANCE DISORDER 25 0.0003
807 MULTI-ORGAN FAILURE 5 0.0003
808 NERVOUS SYSTEM DISORDER 9 0.0003
809 CARDIO-RESPIRATORY ARREST 12 0.0003
810 APHONIA 4 0.0003
811 LUNG DISORDER 14 0.0003
812 SKIN DISCOLOURATION 13 0.0003
813 RENAL FAILURE ACUTE 12 0.0003
814 LYMPHADENOPATHY 10 0.0003
815 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
816 PALPITATIONS 33 0.0003
817 OFF LABEL USE 245 0.0003
818 RECTAL HAEMORRHAGE 12 0.0003
819 VERTIGO 17 0.0003
820 HERPES ZOSTER 16 0.0003
821 INFLUENZA 31 0.0003
822 OEDEMA 15 0.0003
823 MYELODYSPLASTIC SYNDROME 4 0.0003
824 CRYING 10 0.0003
825 IMPAIRED HEALING 9 0.0003
826 BLOOD GLUCOSE DECREASED 13 0.0003
827 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
828 SKIN DISORDER 9 0.0003
829 COLON CANCER 4 0.0003
830 THINKING ABNORMAL 5 0.0003
831 BACTERIAL INFECTION 5 0.0003
832 HAEMORRHAGE INTRACRANIAL 4 0.0003
833 RESPIRATORY DISORDER 8 0.0003
834 BONE LOSS 4 0.0003
835 HEART RATE IRREGULAR 6 0.0003
836 HYPOAESTHESIA ORAL 4 0.0003
837 LACRIMATION INCREASED 8 0.0003
838 CORONARY ARTERY DISEASE 8 0.0003
839 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
840 RHINORRHOEA 17 0.0003
841 PRODUCT USE IN UNAPPROVED INDICATION 65 0.0003
842 SHOCK 6 0.0003
843 PRODUCT DOSE OMISSION 17 0.0003
844 DRUG INTERACTION 41 0.0003
845 JOINT SWELLING 31 0.0003
846 MOOD ALTERED 7 0.0003
847 ACUTE MYELOID LEUKAEMIA 4 0.0003
848 BASAL CELL CARCINOMA 4 0.0003
849 SWOLLEN TONGUE 8 0.0003
850 NASOPHARYNGITIS 47 0.0003
851 PROCEDURAL PAIN 7 0.0003
852 PRODUCT PRESCRIBING ERROR 6 0.0003
853 INFLAMMATION 13 0.0003
854 MEDICATION ERROR 14 0.0003
855 INTENTIONAL PRODUCT MISUSE 22 0.0003
856 VISION BLURRED 34 0.0002
857 PANCREATITIS 13 0.0002
858 WEIGHT INCREASED 55 0.0002
859 DEVICE ISSUE 22 0.0002
860 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
861 CHEST DISCOMFORT 25 0.0002
862 CONDITION AGGRAVATED 74 0.0002
863 VISUAL IMPAIRMENT 30 0.0002
864 CEREBROVASCULAR ACCIDENT 41 0.0002
865 PERITONITIS 5 0.0002
866 LIVER FUNCTION TEST ABNORMAL 7 0.0002
867 AGEUSIA 6 0.0002
868 NEEDLE ISSUE 7 0.0002
869 ASTHMA 27 0.0002
870 ACUTE MYOCARDIAL INFARCTION 7 0.0002
871 MOUTH ULCERATION 5 0.0002
872 GASTRIC CANCER 6 0.0002
873 PARAESTHESIA 37 0.0002
874 GASTROINTESTINAL DISORDER 21 0.0002
875 GASTRIC DISORDER 8 0.0002
876 ANAPHYLACTIC SHOCK 6 0.0002
877 HYPOACUSIS 10 0.0002
878 OCULAR HYPERAEMIA 11 0.0002
879 DRUG ADMINISTRATION ERROR 7 0.0002
880 DRUG INTOLERANCE 22 0.0002
881 DRUG ERUPTION 4 0.0002
882 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 45 0.0002
883 CHROMATURIA 5 0.0002
884 RASH PRURITIC 12 0.0002
885 RHEUMATOID ARTHRITIS 25 0.0002
886 HEPATIC ENZYME INCREASED 15 0.0002
887 HAEMORRHAGE 23 0.0002
888 PRODUCT AVAILABILITY ISSUE 5 0.0002
889 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
890 LUNG NEOPLASM MALIGNANT 9 0.0002
891 BLOOD GLUCOSE ABNORMAL 4 0.0002
892 LACTIC ACIDOSIS 7 0.0002
893 PRURITUS 83 0.0002
894 ARTHROPATHY 12 0.0002
895 THERAPY CESSATION 11 0.0002
896 HOT FLUSH 16 0.0002
897 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
898 PANCREATIC CARCINOMA 6 0.0002
899 GLAUCOMA 4 0.0002
900 BLOOD GLUCOSE INCREASED 39 0.0002
901 RASH 90 0.0002
902 ORAL HERPES 4 0.0002
903 CEREBRAL INFARCTION 5 0.0002
904 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
905 DRY EYE 10 0.0002
906 RASH MACULAR 7 0.0002
907 ALOPECIA 39 0.0002
908 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
909 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
910 INTENTIONAL SELF-INJURY 4 0.0002
911 PSORIATIC ARTHROPATHY 8 0.0002
912 NEUTROPHIL COUNT DECREASED 8 0.0002
913 DIPLOPIA 5 0.0002
914 C-REACTIVE PROTEIN INCREASED 7 0.0002
915 DRUG-INDUCED LIVER INJURY 6 0.0002
916 DERMATITIS 4 0.0002
917 HALLUCINATION, VISUAL 4 0.0002
918 ADVERSE DRUG REACTION 17 0.0002
919 MULTIPLE SCLEROSIS 9 0.0002
920 EYE SWELLING 7 0.0002
921 BREAST CANCER FEMALE 5 0.0002
922 INTENTIONAL OVERDOSE 12 0.0002
923 MOVEMENT DISORDER 6 0.0002
924 JAUNDICE 5 0.0002
925 CATARACT 11 0.0002
926 DEVICE DISLOCATION 8 0.0002
927 EYE DISORDER 6 0.0002
928 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
929 GLOSSODYNIA 4 0.0002
930 SKIN EXFOLIATION 15 0.0002
931 TARDIVE DYSKINESIA 5 0.0002
932 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
933 DYSGEUSIA 13 0.0002
934 ANGINA PECTORIS 5 0.0002
935 EYE IRRITATION 10 0.0002
936 NIGHTMARE 6 0.0002
937 DRUG INEFFECTIVE 223 0.0002
938 ERYTHEMA 34 0.0002
939 INTERSTITIAL LUNG DISEASE 8 0.0002
940 DISCOMFORT 10 0.0002
941 ADVERSE EVENT 15 0.0002
942 INJECTION SITE MASS 6 0.0002
943 EMOTIONAL DISORDER 5 0.0002
944 FEMUR FRACTURE 5 0.0002
945 VAGINAL HAEMORRHAGE 7 0.0002
946 LIVER DISORDER 7 0.0002
947 FLUSHING 16 0.0002
948 HEPATITIS 4 0.0002
949 MYOCARDIAL INFARCTION 27 0.0002
950 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
951 UNDERDOSE 11 0.0002
952 LIP SWELLING 5 0.0001
953 HYPERSENSITIVITY 27 0.0001
954 URTICARIA 24 0.0001
955 DEVICE MALFUNCTION 10 0.0001
956 PRODUCT ADHESION ISSUE 5 0.0001
957 CEREBRAL HAEMORRHAGE 5 0.0001
958 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
959 INFUSION RELATED REACTION 9 0.0001
960 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
961 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
962 RASH ERYTHEMATOUS 6 0.0001
963 PRODUCT QUALITY ISSUE 16 0.0001
964 THERAPEUTIC RESPONSE DECREASED 7 0.0001
965 DEVICE USE ERROR 4 0.0001
966 COLITIS ULCERATIVE 5 0.0001
967 INFLUENZA LIKE ILLNESS 9 0.0001
968 HEPATIC FUNCTION ABNORMAL 4 0.0001
969 FLATULENCE 6 0.0001
970 INCORRECT DOSE ADMINISTERED 24 0.0001
971 ECZEMA 5 0.0001
972 NO ADVERSE EVENT 17 0.0001
973 PRODUCT STORAGE ERROR 8 0.0001
974 ANGIOEDEMA 4 0.0001
975 INJECTION SITE PAIN 27 0.0001
976 INJECTION SITE BRUISING 7 0.0001
977 BLOOD CHOLESTEROL INCREASED 4 0.0001
978 TREATMENT FAILURE 7 0.0001
979 PSORIASIS 11 0.0001
980 ACNE 6 0.0001
981 DRUG DOSE OMISSION BY DEVICE 6 0.0001
982 DEVICE DIFFICULT TO USE 5 0.0001
983 BREAST CANCER 7 0.0001
984 PROSTATE CANCER 6 0.0001
985 INJECTION SITE REACTION 5 0.0001
986 COMPLETED SUICIDE 6 0.0001
987 SKIN BURNING SENSATION 5 0.0001
988 EXPOSURE DURING PREGNANCY 4 0.0001
989 INJECTION SITE HAEMORRHAGE 5 0.0001
990 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
991 DRUG DOSE OMISSION 9 0.0001